Company intelligence / Profile preview

Neuro Serge

Lille, Hauts-de-France, France

Ownership: Private
Development stage: Other

Overview

NeuroSerge was a French medical technology company that developed a robotic system for minimally invasive neurosurgery. The company specialized in robotic-assisted interstitial laser thermotherapy (LITT), a technique used to treat brain tumors and drug-resistant epilepsy with high precision. Its platform integrated robotics with laser ablation to provide a less invasive alternative to traditional open-brain surgery. Founded as a spin-off from the University of Lille and Inserm, the company aimed to commercialize advanced surgical tools before its liquidation in 2019.

Therapeutic areas: OncologyNeurology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

InsermUniversity of LilleCHRU de Lille

Beyond the preview

Go deeper on Neuro Serge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuro Serge.

Explore the full profile